Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory
USPTO PatentsView assignee record - 26 granted patents across 23 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Zhejiang ranks #11,889 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 23 technology areas.
- #11,889
- of 49,997 US assignees by volume
- Top 43%
- by Innovation Score (37.7/100)
- 10.0
- avg claims per patent
- -67%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R11889 · Foreign Corporation #11,889 · 26 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 26 grants
- UPPER-Q #11,889/49,997
- PHOTO-FINISH Zak Designs
- CPC-FOCUS A61K · 23 areas
- INNOV-THIN 37.7/100
- CLAIMS-PAR 10.0 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -67% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Zak Designs, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Zhejiang’s 37.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Zhejiang
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Gen9 · near
Gen9 · near
38 score
- Icron · near
Icron · near
38 score
- Lucite International… · near
Lucite International… · near
38 score
- Qingdao Goertek… · near
Qingdao Goertek… · near
38 score
- Zhejiang Medicine… · this assignee
Zhejiang Medicine… · this assignee
38 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Zhejiang's Innovation Score is 37.7/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Zhejiang?
Each dot is one of Zhejiang’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Zhejiang’s own 10.0 claims/patent is at or below the 12.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Zhejiang's grants concentrate
Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory is a focused PatentsView assignee: 23 CPC subclasses with 53.8% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2018 (7 grants) versus a trough of 2 in 2017. By volume, Zhejiang sits between Zest IP Holdings, LLC and Agena Bioscience, Inc..
Zhejiang's three-year grant acceleration
Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Zhejiang's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Zest IP Holdings
Zest IP Holdings, LLC
26 patents
- Zhejiang E-P Equi…
Zhejiang E-P Equipment Co., Ltd.
26 patents
- Zoomlion Heavy In…
Zoomlion Heavy Industry NA, Inc.
26 patents
- Zak Designs
Zak Designs, Inc.
26 patents
- Zhejiang Medicine… ◀
Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory
26 patents
- 360 Electrical L…
360 Electrical, L.L.C.
25 patents
- Aalyria
Aalyria Technologies, Inc.
25 patents
- Adisseo France S
Adisseo France S.A.S.
25 patents
- Agena Bioscience
Agena Bioscience, Inc.
25 patents
What this shows Zhejiang holds 26 patents at rank #11,890, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Zhejiang
By rank, the assignees closest to #11,890 in granted patent volume.
- Zest IP Holdings, LLC #11,886 · 26 patents
- Zhejiang E-P Equipment Co., Ltd. #11,887 · 26 patents
- Zoomlion Heavy Industry NA, Inc. #11,888 · 26 patents
- Zak Designs, Inc. #11,889 · 26 patents
- 360 Electrical, L.L.C. #11,891 · 25 patents
- Aalyria Technologies, Inc. #11,892 · 25 patents
- Adisseo France S.A.S. #11,893 · 25 patents
- Agena Bioscience, Inc. #11,894 · 25 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Zhejiang's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Zhejiang, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Zhejiang ranks #1,619 of 7,163 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (38 here).
Zhejiang's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
38 Top 43% higher than 57% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 6 | 23.1% |
| 2016 | 3 | 11.5% |
| 2017 | 2 | 7.7% |
| 2018 | 7 | 26.9% |
| 2020 | 2 | 7.7% |
| 2021 | 2 | 7.7% |
| 2024 | 2 | 7.7% |
| 2025partial year | 2 | 7.7% |
Which technologies does Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory patent most?
Top 15 of 23 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory's patent record in context - here's where to go next.
- Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 53.8% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #11,889 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory against Zest IP Holdings, LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 37.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.